SCHEMBL10039712

SCHEMBL10039712

NCC(=O)N1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)cc3c2OCC3)CC1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10039736 0.91 PARP1 (0.69) PARP1
SCHEMBL10039810 0.90 PARP1 (0.65) PARP1
SCHEMBL10039749 0.90 PARP1 (0.68) PARP1
SCHEMBL10039888 0.89 PARP1 (0.67) PARP1
SCHEMBL10039728 0.88 PARP1 (0.66) PARP1
SCHEMBL10039711 0.88 PARP1 (0.64) PARP1
SCHEMBL10039754 0.88 PARP1 (0.66) PARP1
SCHEMBL10039887 0.87 PARP1 (0.69) PARP1
SCHEMBL10039875 0.87 PARP1 (0.69) PARP1
SCHEMBL10039691 0.87 PARP1 (0.65) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019430-A1 PHTHALAZINONE DERIVATIVE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 WO disclosed